MBM. N. Boldyreva

M. N. Boldyreva

*This is an algorithmically generated author record based on publicly available information.

M. N. Boldyreva has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is there an association between vaginal, urethral and urinary microbiota in women with urogenital tract diseases?

    by M. Boldyreva, A. Ivanova, M. Petrunicheva, A. Morozov, Z. Moskvina, K. Rossolovskaya, L. Spivak, М. Болдырева, А. Иванова, М. Петруничева, et al.

    Urinary tract infections (UTI), including recurrent cystitis, are usually interpreted in relation to dominant uropathogens. However, the microbial context of adjacent urogenital sites may also be relevant. Aim. To evaluate the association between UTI and the microbiota of different parts of the urogenital tract in order to provide insights into disease pathogenesis and treatment. Material and methods. The study included three groups: healthy volunteer group (n= 34); patients at risk of developing UTI (women with micronephrolithiasis and/or bacterial vaginosis; n = 16); and patients with a history of recurrent lower UTI (n = 100). Four types of biomaterial were used: first-pass and midstream urine samples, urethral and vaginal swabs. All samples were analyzed by multiplex real-time polymerase chain reaction reagent kits Femoflor®16 and BacScreen OM. Results. Genomic DNA and total bacterial quantities increased while relative lactobacilli decreased in patients with a risk of UTI and in those with recurrent lower UTI. This was only the case in midstream and first-pass urine samples. Relative lactobacilli levels in the urethral and vaginal swabs were only slightly but statistically significantly reduced in patients with recurrent lower UTI. Facultative anaerobes predominated in urine samples of patients with a risk of UTI, while in patients with recurrent lower UTI an increase in both facultative and obligate anaerobes was observed. Conclusion. Midstream and first-pass urine samples can reliably assess inflammation in the urogenital tract. No strict correlation was observed between the vaginal and urinary microbiota of patients with recurrent lower UTI, meaning that UTI do not necessarily affect the vaginal biotope.

  • Microbial skin colonization in patients with atopic dermatitis: Association with immunological parameters and clinical disease severity

    by K. K. Nosyreva, O. G. Elisyutina, E. V. Smolnikov, D. P. Shut, E. S. Fedenko, M. N. Boldyreva

    Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by impaired epidermal barrier function, immune dysregulation, and altered microbial ecology. Over recent decades, there has been a steady increase in its prevalence, making AD one of the most pressing issues in dermatology. The aim of this study was to comprehensively assess bacterial skin colonization in patients with AD using real-time quantitative PCR and to analyze its relationship with clinical and immunological parameters of the disease. A prospective study included 110 patients with AD and 86 apparently healthy individuals. The disease severity was assessed using the SCORAD index; total IgE levels and complete blood count were measured, and quantification of skin microbiota was performed by real-time PCR. The results revealed a significant increase in bacterial load in the AD group compared to controls: total bacterial mass was 32 times higher, while Staphylococcus spp. and Staphylococcus aureus were 100 times higher. The concentration of Streptococcus spp. did not differ significantly. A strong positive correlation was found between the SCORAD index, total IgE level, absolute eosinophil count, and the quantity of total bacterial mass, Staphylococcus spp., and S. aureus , whereas a weak negative correlation was observed for Streptococcus spp. Patients with severe AD had significantly higher IgE levels. The obtained data confirm the central role of S. aureus and microbial dysbiosis in AD pathogenesis. The established threshold values of bacterial load (total bacterial mass > 5.0 log copies/mL, S. aureus > 4.0 log copies/mL) may serve as objective criteria for prescribing targeted antimicrobial therapy.

  • Comparative analysis of skin fungal colonization in patients with atopic dermatitis and healthy individuals

    by K. K. Nosyreva, O. G. Elisyutina, D. P. Shut, E. V. Smolnikov, E. S. Fedenko, M. N. Boldyreva

    Atopic dermatitis is a chronic, relapsing inflammatory skin disease. Immune dysregulation occurs, leading to inflammation in response to allergens that penetrate through a compromised epidermal barrier. Defects in the skin barrier and inflammatory processes in the skin result in increased colonization by conditionally pathogenic microorganisms. Fungal microbiota dysbiosis ( Malassezia spp. and others) is considered one of the factors involved in the pathogenesis of atopic dermatitis. However, the influence of fungal microflora on atopic dermatitis remains less studied compared to the role of bacterial microorganisms. The aim of this study was to conduct a comparative analysis of the prevalence of fungi in patients with atopic dermatitis and a control group using real-time polymerase chain reaction. The study included 151 participants. The group of patients with atopic dermatitis included lesions from different locations, and for more accurate comparison. The control group was formed considering both dry skin areas and areas with increased sebum production. All patients had their diagnosis of atopic dermatitis confirmed according to clinical guidelines. Disease severity was assessed using the SCORAD index. Epithelial scrapings were collected depending on lesion location. The obtained skin samples were analyzed using real-time PCR. It was found that patients with atopic dermatitis exhibited significantly higher levels of fungal colonization compared to the control group. Specifically, patients with atopic dermatitis more frequently harbored various yeast species such as Candida , Malassezia , and Saccharomyces cerevisiae , as well as non-dermatophyte molds like Aspergillus spp. /Penicillium spp. Additionally, we observed that the distribution of Candida and Malassezia restricta species varies depending on the severity of atopic dermatitis. Changes in the fungal composition of the skin play an important role in the pathogenesis of atopic dermatitis, potentially activating the immune system and exacerbating inflammatory processes. Although fungi are not direct causative agents of atopic dermatitis, an imbalance in their populations likely contributes to disease exacerbation and progression. Further research is needed to better understand how fungi influence atopic dermatitis development particularly studies focusing on immune responses to fungi and allergy mechanisms related to their alterations. Such data could aid in developing new therapeutic and preventive strategies for this condition.

  • Open Access

    Placebo-controlled clinical trial of the effectiveness of D-Mannose Supercomplex in the prevention of recurrent UTI.

    by Z.V. Moskvina, Russia Moscow, M.N. Boldyreva, K.A. Rossolovskaya, M.S. Evdokimov, Russia Family Polyclinic No. 4; Korolev, D.V. Platonova, Ts.G. Magomedov, L.G. Spivak

    Introduction. In recent years, the use of D-mannose as an alternative to antimicrobial agents has been widely discussed in the literature due to the fact that when applied topically, it reduces the ability of E. coli to bind to the urothelium. The aim of this study was to evaluate the change in the number of relapses during the observation period in patients who used «D-Mannose Supercomplex» as a metaphylaxis of cystitis in comparison with the control group, which received a placebo instead of this product. Materials and methods. A multicenter, randomized, double-blind, placebo-controlled, prospective clinical study was conducted to evaluate the efficacy and safety of a dietary supplement containing 2000 mg of D-mannose, 100 mg of cranberry extract, 80 mg of bearberry extract (8 mg of arbutin), and 30 mg of magnesium. Results. In animal models, the use of D-mannose led to a significant decrease in the bacterial load. The use of «D-Mannose Supercomplex» prolongs the relapse-free period in patients with RUTI after the end of antibacterial therapy. The duration of the relapse-free period correlates with the duration of D-mannose intake, which is consistent with modern concepts of the mechanism of action of the drug. The drug is well tolerated by patients. The number of adverse events (AE) in the «D-Mannose Supercomplex» and placebo groups was comparable. AE and allergic reactions associated, according to the researchers, with the use of the study drug, were not registered during the administration of the drug. Conclusions. The presented study data indicate that complex drugs containing D-mannose, cranberry extract, bearberry and magnesium (for example, «D-Mannose Supercomplex») can be considered from the standpoint of evidence-based medicine as a promising means of complex etiopathogenetic therapy for prolonging the relapse-free period in patients with exacerbation of recurrent urinary tract infection (RUTI).

  • Open Access

    Features of the parietal and cavity intestinal microbiota in infants born to mothers with bronchial asthma, depending on the mode of delivery

    by T. V. Kosenkova, V. P. Novikova, E. A. Boytsova, И. А. Кельмансон, I. E. Zazerskaya, O. V. Lavrova, M. N. Boldyreva

    Introduction. Intestinal microbiota is a complex and unique system in its composition, performing a huge number of diverse functions in the body. Its formation begins in utero.Aim. To study the features of the parietal and cavity intestinal microbiota in children born to mothers suffering from moderate bronchial asthma, depending on the mode of delivery.Material and methods. A prospective longitudinal study was carried out, which included children from the first day of life to 12 months. A total of 68 children at high risk of atopy (HRA) from mothers with asthma were included, of whom 22 were born by cesarean section and 46 were born through the vaginal birth canal. Qualitative and quantitative analysis of GM was carried out by real-time PCR with group- and species-specific primers: in the examined children, the dynamics of 4 phylums including 31 microorganisms was assessed. The child’s feces and brush-biopsy were taken from the rectum at 7 control points of measurement.Results and discussion. The data obtained showed that the method of delivery has an impact on the formation of the intestinal microbiota: in children born by cesarean section, in the parietal microbiota, starting from the age of 1–2 months, and in the cavity microbiota – 3–4 months, representatives of phylum Firmicutes (Clostridium leptum gr m.). In children born through the vaginal birth canal, all the first 8 months of life in the cavity and parietal microbiota were dominated by representatives of phylum Bacteroidetes (Bacteroides spp., Prevotella spp.). Clostridium leptum can be a marker of an inflammatory process in the intestinal mucosa in children at high risk of atopy. The research conducted over the past few years has found that Clostridium leptum promotes the secretion of anti-inflammatory (IL-10 and IL-12) and inhibition of the production of pro-inflammatory (IL-8) cytokines, and also boosts the number of Treg cells.Conclusion. The mode of delivery in children with a high risk of atopy is an additional epigenetic factor that influences the nature of both the parietal and cerebrospinal microbiota.


  • Open Access

    The role of D-mannose and proanthocyanidins in cranberries in the prevention of recurrent urinary tract infections.

    by Moskvina Z.V., Boldyreva M.N., Rossolovskaya K.A., Spivak L.G.

    Introduction. Prevention of urinary tract infections (UTI) is an urgent problem due to their high prevalence. Regular use of antibiotics, especially when recurrent urinary tract infections occur, cont

  • Open Access

    HLA-A, -B, -DRB1 genes polymorphism of in COVID-19 patients

    by E.M. Rodnikova, Infectious Clinical Hospital No. 1 of the Moscow Health Department, K.R. Dudina, T.E. Yankevich, V.V. Kadochnikova, M.N. Boldyreva, D.Yu. Trofimov

    Полиморфизм генов HLA-A, -B, -DRB1 у пациентов с COVID-19


  • Open Access

    Real-time RT-PCR diagnostics of virus causing COVID-19

    by E. V. Goncharova, A. E. Donnikov, V. V. Kadochnikova, S. A. Morozova, M. N. Boldyreva, I. S. Galkina, D. V. Blinov

    Aim: the study was aimed to develop a reagent kit for the real-time RT-PCR diagnostics of virus causing COVID-19.Materials and Methods.Three target sites were chosen in the genome SARS-CoV-2. The testing included 220 samples, 48 artificially created positive samples (made from patients’ biomaterial) and 172 clinical samples (scrapes from nasal and pharyngeal cavities, bronchoalveolar lavage, expectoration, endotracheal/nasopharyngeal aspirate, feces, post-mortem material), obtained from two medical centers. Preliminary, the obtained biomaterial was analyzed with a reagent kit of comparison. The evaluation was performed with a confidential interval CI 95%. The calculation of CI for the sensitivity and specificity was made based on the distribution of χ2.Results.The authors developed a technology of novel coronavirus infection (COVID-19) real-time RT-PCR diagnostics for the application in practical healthcare and proposed the variants of testing at all the stages (preanalytical, analytical, and post-analytical, including automated results processing). The proposed reagent kit meets the requirements of the World Health Organization and the Ministry of Healthcare of the Russian Federation. The study results demonstrated high sensitivity and specificity. The sensitivity was 100% (95% CI) 95.6–100%; the specificity was 100% (95% CI) 96.7–100%.Conclusion.The proposed reagent kit was registered in the RF as a medical product; the registration certificate No. RZN 2020/9948 dated 01.04.2020. The application of the reagent kit in network laboratories will provide patients with access to testing for the virus causing COVID-19 and contribute to quick differential diagnostics, improvement of pandemic control, and accurate statistics on the spread of the virus.


  • SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections

    by M.N. Boldyreva, National Research Center – Institute of Immunology of the Federal Medical-Biological Agency